Annals of Oncology

In this issue:

In this issue
Ann Oncol 5: 295.
[PDF] [Request Permissions]

Contents of the next issue:

Contents of the next issue
Ann Oncol 5: 295.
[PDF] [Request Permissions]

News:

NCI-EORTC Conference honors Michel Clavel
Ann Oncol 5: 296.
[PDF] [Request Permissions]

Plans for a Euro-American summit on breast cancer
Ann Oncol 5: 296-297.
[PDF] [Request Permissions]

G.E.L.A.: Ten years and an example
Ann Oncol 5: 297.
[PDF] [Request Permissions]

Mitterrand pressured to pardon physicians
Ann Oncol 5: 297-298.
[PDF] [Request Permissions]

Indignation over secret U.S. experiments: Increased cancer incidence?
Ann Oncol 5: 298.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 5: 299.
[PDF] [Request Permissions]

Editorials:

V. Dielhl, H. Bohlen, and J. Wolf

CD 30: Cytokine-receptor, differentiation marker or a target molecule for specific immune response?
Ann Oncol 5: 300-302.
[PDF] [Request Permissions]

Silvia Marsoni and Maurizia Clerici

Efficacy, semantic and chemotherapy in advanced NSCLC
Ann Oncol 5: 303-304.
[PDF] [Request Permissions]

Review:

P. S. Craft and A. L. Harris

Clinical prognostic significance of tumour angiogenesis
Ann Oncol 5: 305-311.
[Abstract] [PDF] [Request Permissions]

Book reviews:

P. Huguenin

Book review
Ann Oncol 5: 311-312.
[PDF] [Request Permissions]

R. O. Mirimanoff

Book review
Ann Oncol 5: 312.
[PDF] [Request Permissions]

M.H. Bronchud

Book review
Ann Oncol 5: 327-328.
[PDF] [Request Permissions]

Aron Goldhirsch

Book review
Ann Oncol 5: 368.
[PDF] [Request Permissions]

Commentary:

L.M. Minasian and B. Gansbacher

Second International Conference on Gene Therapy of Cancer
Ann Oncol 5: 313-316.
[PDF] [Request Permissions]

Original articles:

J. E. Romaguera, J. T. Manning, Jr., C. S. Tornos, J. Rodriguez, T. E. Brooks, W. C. Pugh, N. G. Ordonez, A. M. Goodacre, and E. Cabanillas

Long term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma
Ann Oncol 5: 317-322.
[Abstract] [PDF] [Request Permissions]

M. González Barón, J. Feliu, E. Espinosa, C. García Girón, E. Blanco, P. Garrido, A. Colmenarejo, A. Ordóñez, A. Moyano, I. de la Gándara, P. Zamora, and ONCOPAZ Cooperative Group

Comparison of two chemotherapeutic regimens – mitomycin + vindesine 4-cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP) – in advanced non-small-cell lung cancer
Ann Oncol 5: 323-327.
[Abstract] [PDF] [Request Permissions]

P. Eng Tan, C. C. Benz, C. Dollbaum, D. H. Moore, II, S. M. Edgerton, D. T. Zava, and A. D. Thor

Prognostic value of Cathepsin D expression in breast cancer: Immunohistochemical assessment and correlation with radiometric assay
Ann Oncol 5: 329-336.
[Abstract] [PDF] [Request Permissions]

F. Boccardo, A. Rubagotti, A. Perrotta, D. Amoroso, M. Balestrero, A. De Matteis, P. Zola, P. Sismondi, G. Francini, R. Petrioli, M. Sassi, P. Pacini, and E. Galligioni

Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: Results of a multicentric Italian study
Ann Oncol 5: 337-342.
[Abstract] [PDF] [Request Permissions]

A. M. Oza, W. ten Bokkel Huinink, R. Dubbelman, O. Soepenberg, I. Mandjes, E. Aartsen, and J. G. McVie

Phase I/II study of intraperitoneal mitoxantrone in refractory ovarian cancer
Ann Oncol 5: 343-347.
[Abstract] [PDF] [Request Permissions]

M. Krogh-Jensen, F. d'Amore, M. K. Jensen, B. E. Christensen, K. Thorling, M. Pedersen, P. Johansen, A. M. Boesen, and E. Andersen

Incidence, clinicopathological features and outcome of primary central nervous system lymphomas: Population-based data from a Danish lymphoma registry
Ann Oncol 5: 349-354.
[Abstract] [PDF] [Request Permissions]

P. M. Petersen, S. W. Hansen, A. Giwercman, M. Rørth, and N. E. Skakkebæk

Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer
Ann Oncol 5: 355-358.
[Abstract] [PDF] [Request Permissions]

J. J. Body and J. C. Dumon

Treatment of tumour-induced hypercalcaemia with the bisphosphonate pamidronate: Dose-response relationship and influence of tumour type
Ann Oncol 5: 359-363.
[Abstract] [PDF] [Request Permissions]

Clinical case:

U. Kaiser, K.-H. Pflüger, M. Tiemann, and K. Havemann

Malignant Iymphoma versus sarcoma: Discordance between clinical course and immunocytochemistry: Two case reports
Ann Oncol 5: 365-368.
[PDF] [Request Permissions]

Short reports:

G. Michel, S. Leyvraz, J. Bauer, M. Aapro, R. Stahel, and P. Alberto

Weekly carboplatin and VM-26 for elderly patients with small-cell lung cancer
Ann Oncol 5: 369-370.
[Abstract] [PDF] [Request Permissions]

S. Bodis and A. Haregewoin

Significantly reduced salivary nitric oxide levels in smokers
Ann Oncol 5: 371-372.
[Abstract] [PDF] [Request Permissions]

A. S. T. Planting, J. H. M. Schellens, S. H. Goey, M. E. L. van der Burg, M. de Boer-Dennert, G. Stoter, and J. Verweij

Weekly high-dose cisplatin in malignant pleural mesothelioma
Ann Oncol 5: 373-374.
[Abstract] [PDF] [Request Permissions]

J. Verweij, J. Wanders, A. L. Nielsen, N. Pavlidis, F. Calabresi, W. ten Bokkel Huinink, U. Bruntsch, M. Piccart, H. Franklin, S. B. Kaye, and On behalf of the EORTC Early Clinical Trials Group

Phase II studies of Elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer and ovarian cancer
Ann Oncol 5: 375-376.
[Abstract] [PDF] [Request Permissions]

Letters:

W. Hoffmann, H. P. Rodemann, H. Schmidberger, B. Weiss, and M. Bamberg

Letters to the editor: Enhanced muco-cutaneous toxicity of radiotherapy in a patient with chronic GVHD and secondary malignancy
Ann Oncol 5: 377-378.
[PDF] [Request Permissions]

A. Surbone

Letters to the editor: More on euthanasia
Ann Oncol 5: 378-379.
[PDF] [Request Permissions]

S. Al-Bahar, R. Pandita, B. N. Dhabhar, and E. Al-Bahar

Letters to the editor: Acute tumor lysis syndrome in acute lymphoblastic leukemia and Burkitt's lymphoma: Experience in a single centre in Kuwait
Ann Oncol 5: 379.
[PDF] [Request Permissions]

Advertisements in this issue:

Kluwer Academic Publishers
Ann Oncol 5: 381.
[PDF] [Request Permissions]

Kluwer Academic Publishers
Ann Oncol 5: 382.
[PDF] [Request Permissions]

Classfied advertisements from ESMO members and meeting announcements
Ann Oncol 5: 383.
[PDF] [Request Permissions]

ESMO membership application forms
Ann Oncol 5: 384.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.